Key Highlights
- Highlander Health launched by co-founders Amy Abernethy, M.D., Ph.D., and Brad Hirsch, M.D.
- Focus on integrating research into clinical care to improve treatments and patient outcomes.
- Comprised of Highlander Health Institute and Highlander Health Partners, combining public interest and investment arms.
- Focus on technology enablement in growth and middle-market companies across health care.
Source: Business Wire
Notable Quotes
- “After more than five decades in health care, and seeing the industry’s challenges from all angles, Brad and I are more optimistic than ever. Our experience … illuminates the bold solutions needed.” — Amy Abernethy, co-founder at Highlander Health
- “There is an enormous opportunity to improve clinical research and care, particularly at their intersection … we’ve only scratched the surface.” — Brad Hirsch, co-founder at Highlander Health
SoHC's Take
The launch of Highlander Health is a significant step toward a future where research and care are seamlessly integrated. Co-founders Amy Abernethy and Brad Hirsch, both industry veterans, bring a wealth of experience and a vision for transforming clinical research through personalized approaches. By supporting ecosystem collaboration and technology innovation, Highlander Health is well-positioned to tackle critical challenges in evidence generation, improving outcomes for both patients and the healthcare system.
Related

Highlander Health Acquires Target RWE to Advance Personalized Care
Key Highlights Highlander Health acquires Target RWE, a leader in real-world evidence, to enhance clinical research and personalized care.Target RWE specializes in high-quality longitudinal data, supporting drug development and clinical strategies in the US and Europe.Highlander Health Partners, co-founded by Amy Abernethy, M.D., Ph.D., and Brad Hirsch, M.D., aims to…

Dr. Chris Bahl Appointed CEO of AI Proteins
Key Highlights Dr. Chris Bahl, founder and President, now appointed as CEO of AI Proteins. Brings expertise in de novo protein design and groundbreaking AI-based drug discovery. AI Proteins to present at Biotech Showcase 2025 during JP Morgan Healthcare Conference. Innovative platform accelerates creation of therapeutic proteins for unmet medical…

Companies to Watch – Editor’s Choice 2025
Welcome to the highly anticipated Slice of Healthcare 2025 Companies to Watch – Editor's Choice! Curated by Jared S. Taylor, this year's list highlights 30 remarkable healthcare companies poised to make a meaningful impact in 2025. Let's kick off the year by celebrating these standout innovators shaping the future of…